Consultation on a broad range of topics related to drug discovery and development including grant strategy, collaboration, and industrial partnership
Drug Discovery and Development Consulting Unit
Reference compound synthesis to synthesize commercially unavailable compounds of key biological and pharmacological interest to core users as reference and/or tool compounds.
Contact:
Takashi Tsukamoto, PhD., 443-629-7984, [email protected]
Biochemical and assay development support will assist biochemical assays development for putative therapeutic targets along with Cell-based assay development support that will facilitate development of cell-based drug screening assays. The Drug Screening Library maintains, distributes, and screens drug library (FDA approved) compounds. This library is ideal for re-purposing licensed drugs by screening activity against new targets.
Contact:
Ajit Thomas, [email protected]. (Screening Unit)
Jun Liu, PhD., 410-955-4619, [email protected] (Drug Library)
In vitro metabolic stability assessment will help users predict drug metabolism by measuring in vitro stability in plasma, liver microsomes, S9, and hepatocytes from various species (mouse, rat, dog, monkey, human).
Contact:
Rana Rais, PhD., (410) 614-1906, [email protected]
